| scholarly article | Q13442814 |
| P2093 | author name string | Kazuo Tsubota | |
| Tetsuya Kawakita | |||
| Masaki Fukui | |||
| Saori Yaguchi | |||
| Yoko Ogawa | |||
| Yumiko Saijo-Ban | |||
| Mizuka Kamoi | |||
| Shin Mukai | |||
| Mio Yamane | |||
| Shigeto Simmura | |||
| P2860 | cites work | Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye | Q84866842 |
| Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye | Q86904838 | ||
| P2Y2 receptor agonists for the treatment of dry eye disease: a review | Q24608339 | ||
| Morphologic evaluation of meibomian glands in chronic graft-versus-host disease using in vivo laser confocal microscopy | Q34057206 | ||
| A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye. | Q34332957 | ||
| National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report | Q34474243 | ||
| Character of ocular surface mucins and their alteration in dry eye disease | Q34600435 | ||
| Distribution of mucins at the ocular surface | Q35755130 | ||
| Ocular cicatricial pemphigoid: manifestations and management | Q36168693 | ||
| Resolution of persistent corneal erosion after administration of topical rebamipide | Q36222177 | ||
| A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients | Q36296284 | ||
| Concept of functional visual acuity and its applications | Q36946438 | ||
| International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I). | Q37365681 | ||
| Diquafosol ophthalmic solution for dry eye treatment | Q38030453 | ||
| Ocular graft-versus-host disease | Q38034638 | ||
| Graft versus host disease: clinical evaluation, diagnosis and management | Q38090503 | ||
| Rebamipide increases barrier function and attenuates TNFα-induced barrier disruption and cytokine expression in human corneal epithelial cells | Q39163094 | ||
| Protection of human corneal epithelial cells from TNF-α-induced disruption of barrier function by rebamipide | Q39182147 | ||
| Mucosal microvilli in dry eye patients with chronic GVHD. | Q42488324 | ||
| A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. | Q42497780 | ||
| Rebamipide suppresses PolyI:C-stimulated cytokine production in human conjunctival epithelial cells | Q43988218 | ||
| Localization of ocular P2Y2 receptor gene expression by in situ hybridization | Q44489521 | ||
| Rebamipide increases the amount of mucin-like substances on the conjunctiva and cornea in the N-acetylcysteine-treated in vivo model | Q44981253 | ||
| The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study | Q45284543 | ||
| The application of a new continuous functional visual acuity measurement system in dry eye syndromes | Q45284546 | ||
| Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye. | Q45372415 | ||
| Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD. | Q45919311 | ||
| A multicenter, open-label, 52-week study of 2% rebamipide (OPC-12759) ophthalmic suspension in patients with dry eye. | Q45984720 | ||
| Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren's syndrome: a double-blind placebo-controlled multicenter trial | Q46194450 | ||
| Suppressive effects of tranilast on eotaxin-1 production from cultured conjunctival fibroblasts | Q46795284 | ||
| Impact of ocular graft-versus-host disease on visual quality of life in patients after allogeneic stem cell transplantation: questionnaire study | Q48257835 | ||
| OPC-12759 increases proliferation of cultured rat conjunctival goblet cells. | Q50478784 | ||
| Diagnostic tests in the Sicca syndrome | Q70112003 | ||
| Three different types of dry eye syndrome | Q72066229 | ||
| Role of heat shock protein 47, a collagen-binding chaperone, in lacrimal gland pathology in patients with cGVHD | Q79837297 | ||
| The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) | Q80347907 | ||
| Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease | Q81551290 | ||
| Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial | Q84472814 | ||
| P433 | issue | 4 Suppl 1 | |
| P304 | page(s) | S25-32 | |
| P577 | publication date | 2015-04-01 | |
| P1433 | published in | Optometry and Vision Science | Q15716649 |
| P1476 | title | Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye. | |
| P478 | volume | 92 |
| Q57378488 | Current and emerging therapy of dry eye disease. Part A: pharmacological modalities |
| Q37242107 | Do Cyclosporine A, an IL-1 Receptor Antagonist, Uridine Triphosphate, Rebamipide, and/or Bimatoprost Regulate Human Meibomian Gland Epithelial Cells? |
| Q64066727 | Rebamipide ophthalmic solution modulates the ratio of T helper cell 17/regulatory T cells in dry eye disease mice |
| Q89616710 | Update of P2Y Receptor Pharmacology: IUPHAR Review:27 |
Search more.